Mike Rosenbluth
CEO
Swing Therapeutics, Inc.
Swing Therapeutics develops evidence-backed digital therapies to help individuals with chronic conditions manage their symptoms. Their FDA-cleared product, Stanza, offers a prescription-based digital behavioral therapy for fibromyalgia treatment. This software-based approach provides convenient, non-drug interventions aimed at improving patient wellbeing and quality of life.
- Digital Health
- Healthcare Technology
- Software Only
Updated 21 months ago
Funding
Raised to date
$10.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Patients with chronic conditions, such as fibromyalgia, often face challenges in accessing effective behavioral therapies due to limited availability of trained providers, lack of referral pathways, and high costs. Current FDA-approved medications for fibromyalgia have limited efficacy, significant adverse effects, and high discontinuation rates.
Solution
Swing Therapeutics offers Stanza, an FDA-cleared prescription digital therapeutic designed to help adult patients manage fibromyalgia symptoms. Stanza delivers Acceptance and Commitment Therapy (ACT), a form of Cognitive Behavioral Therapy (CBT), directly to patients via a smartphone app. The program consists of 15-20 minute daily sessions, completed over 12 weeks, that teach self-management skills to cope with pain and prevent symptom flares. Stanza aims to improve psychological symptoms, decrease sleep interference, and increase overall well-being and quality of life without the side effects associated with medication.
Target Audience
The primary target audience includes adult patients diagnosed with fibromyalgia and healthcare providers seeking effective, non-pharmacological treatment options to manage their patients' symptoms.
Features
- Delivers Acceptance and Commitment Therapy (ACT), a form of Cognitive Behavioral Therapy (CBT), via a mobile app
- Provides daily lessons, mindfulness activities, and journaling exercises
- Sends reminders to integrate learned skills into daily life
- Designed for 15-20 minute daily sessions over a 12-week period, with as-needed use after
- Demonstrates improvement in psychological symptoms, sleep quality, and overall well-being in clinical studies
- No treatment-related adverse events or side effects observed in clinical studies
- Compatible with iOS (version 12.0+) and Android (version 8.0+) smartphones